R Schade

2.1k total citations · 1 hit paper
23 papers, 1.5k citations indexed

About

R Schade is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, R Schade has authored 23 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 6 papers in Cardiology and Cardiovascular Medicine and 4 papers in Surgery. Recurrent topics in R Schade's work include Inflammatory mediators and NSAID effects (11 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Gastroesophageal reflux and treatments (3 papers). R Schade is often cited by papers focused on Inflammatory mediators and NSAID effects (11 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Gastroesophageal reflux and treatments (3 papers). R Schade collaborates with scholars based in Germany, Italy and Netherlands. R Schade's co-authors include Edeltraut Garbe, Frank Andersohn, Samy Suissa, Wilhelm Haverkamp, Miriam Sturkenboom, Vera E. Valkhoff, Stefan N. Willich, Ron M. C. Herings, Huub Straatman and Marco Villa and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and PLoS ONE.

In The Last Decade

R Schade

23 papers receiving 1.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation

2007 490 citations R Schade, Frank Andersohn et al. New England Journal of Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
R Schade	377	371	345	288	203	23	1.5k
C. V. Damaraju	294 0.8×	367 1.0×	407 1.2×	363 1.3×	446 2.2×	45	2.1k
Steven Ramael	454 1.2×	190 0.5×	296 0.9×	512 1.8×	282 1.4×	40	2.1k
Michael Messig	629 1.7×	162 0.4×	831 2.4×	536 1.9×	184 0.9×	43	2.0k
Alan Rees	410 1.1×	82 0.2×	669 1.9×	202 0.7×	119 0.6×	36	1.7k
Carlo Piccinni	235 0.6×	117 0.3×	186 0.5×	159 0.6×	222 1.1×	91	1.2k
John Meijer	248 0.7×	96 0.3×	191 0.6×	210 0.7×	229 1.1×	29	1.9k
Alberto Mazza	404 1.1×	126 0.3×	361 1.0×	597 2.1×	47 0.2×	93	1.6k
Norbert Benda	220 0.6×	77 0.2×	154 0.4×	244 0.8×	234 1.2×	83	1.9k
Lynda Booker	521 1.4×	265 0.7×	110 0.3×	232 0.8×	358 1.8×	25	1.8k
Cyrus Desouza	1.3k 3.5×	206 0.6×	450 1.3×	440 1.5×	215 1.1×	108	2.8k

Countries citing papers authored by R Schade

Since Specialization

Citations

This map shows the geographic impact of R Schade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Schade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Schade more than expected).

Fields of papers citing papers by R Schade

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Schade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Schade. The network helps show where R Schade may publish in the future.

Co-authorship network of co-authors of R Schade

This figure shows the co-authorship network connecting the top 25 collaborators of R Schade. A scholar is included among the top collaborators of R Schade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Schade. R Schade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hünger, Matthias, et al.. (2021). The Value of Federated Data Networks in Oncology: What Research Questions Do They Answer? Outcomes From a Systematic Literature Review. Value in Health. 25(5). 855–868. 3 indexed citations

Masclee, Gwen, Huub Straatman, Andrea Arfè, et al.. (2018). Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS project. PLoS ONE. 13(11). e0204746–e0204746. 44 indexed citations

Schink, Tania, Bianca Kollhorst, Andrea Arfè, et al.. (2018). Risk of ischemic stroke and the use of individual non-steroidal anti-inflammatory drugs: A multi-country European database study within the SOS Project. PLoS ONE. 13(9). e0203362–e0203362. 38 indexed citations

Arfè, Andrea, Lorenza Scotti, Cristina Varas‐Lorenzo, et al.. (2016). Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study. BMJ. 354. i4857–i4857. 197 indexed citations

Schade, R, et al.. (2015). P1259 : Hepatitis B in pregnancy in Ukraine: Wasted chance. Journal of Hepatology. 62. S829–S830. 2 indexed citations

Valkhoff, Vera E., R Schade, Geert W. ‘t Jong, et al.. (2013). Population-based analysis of non-steroidal anti-inflammatory drug use among children in four European countries in the SOS project: what size of data platforms and which study designs do we need to assess safety issues?. BMC Pediatrics. 13(1). 192–192. 29 indexed citations

Masclee, Gwen, Vera E. Valkhoff, Eva M. van Soest, et al.. (2013). Cyclo‐oxygenase‐2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?. Alimentary Pharmacology & Therapeutics. 38(2). 178–189. 11 indexed citations

Masclee, Gwen, Vera E. Valkhoff, Eva M. van Soest, et al.. (2013). 1038 Cyclo-Oxygenase-2 Inhibitors or Nonselective NSAIDs Plus Gastroprotective Agents: What to Prescribe in Daily Clinical Practice?. Gastroenterology. 144(5). S–195. 2 indexed citations

Lucchi, S, Bianca Kollhorst, Tania Schink, et al.. (2012). Risk of upper gastrointestinal complications associated with use of individual non-steroidal anti-inflammatory drugs in the SOS Project.. Pharmacoepidemiology and Drug Safety. 21. 2 indexed citations

10.

Valkhoff, Vera E., Eva M. van Soest, Giampiero Mazzaglia, et al.. (2012). Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: A population‐based study. Arthritis & Rheumatism. 64(8). 2792–2802. 13 indexed citations

11.

Trifirò, Gianluca, Mostafa M. Mokhles, Jeanne P. Dieleman, et al.. (2011). Risk of Cardiac Valve Regurgitation with Dopamine Agonist use in Parkinsonʼs Disease and Hyperprolactinaemia. Drug Safety. 35(2). 159–171. 36 indexed citations

12.

Trifirò, Gianluca, Jeanne P. Dieleman, Mendel Haag, et al.. (2011). The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease. Pharmacological Research. 65(3). 358–364. 46 indexed citations

13.

Soest, Eva M. van, Vera E. Valkhoff, Giampiero Mazzaglia, et al.. (2011). Suboptimal gastroprotective coverage of NSAID use and the risk of upper gastrointestinal bleeding and ulcers: an observational study using three European databases. Gut. 60(12). 1650–1659. 55 indexed citations

14.

Valkhoff, Vera E., Eva M. van Soest, Jeanne P. Dieleman, et al.. (2011). Time-Trends in Use of Gastroprotective Strategies With NSAID Treatment in the United Kingdom, Italy, and the Netherlands; A Comparative Study. Gastroenterology. 140(5). S–574. 1 indexed citations

15.

Valkhoff, Vera E., Eva M. van Soest, Giampiero Mazzaglia, et al.. (2011). Adherence to Gastroprotective Agents and the Risk of Upper Gastrointestinal Complications in Coxib Users. Gastroenterology. 140(5). S–585. 1 indexed citations

16.

Andersohn, Frank, R Schade, Stefan N. Willich, & Edeltraut Garbe. (2010). Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior. Neurology. 75(4). 335–340. 96 indexed citations

17.

Andersohn, Frank, R Schade, Samy Suissa, & Edeltraut Garbe. (2009). Long-Term Use of Antidepressants for Depressive Disorders and the Risk of Diabetes Mellitus. American Journal of Psychiatry. 166(5). 591–598. 212 indexed citations

18.

Schade, R, Frank Andersohn, Samy Suissa, Wilhelm Haverkamp, & Edeltraut Garbe. (2007). Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation. New England Journal of Medicine. 356(1). 29–38. 490 indexed citations breakdown →

19.

Schade, R, Frank Andersohn, Samy Suissa, Wilhelm Haverkamp, & Edeltraut Garbe. (2007). Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation. Obstetrical & Gynecological Survey. 62(5). 317–319. 5 indexed citations

20.

Chojkier, Mario, Roberto J. Groszmann, Colin E. Atterbury, et al.. (1979). A controlled comparison of continuous intraarterial and intravenous infusions of vasopressin in hemorrhage from esophageal varices. Gastroenterology. 77(3). 540–546. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact